Pregnane X receptor protects against age-related bone loss in males via PI3K/Akt-mediated inhibition of apoptosis

TL;DR

This study shows that the Pregnane X receptor helps protect male bones from aging by reducing cell death through the PI3K/Akt pathway.

Contribution

The study identifies Pxr as a novel regulator of bone homeostasis via the PI3K/Akt pathway in age-related bone loss.

Findings

Pxr deficiency in bones leads to osteoporotic phenotypes, including reduced bone mass and increased apoptosis.

Pxr overexpression in aged mice restores PI3K/Akt activation and improves bone quality.

Pharmacological activation of Pxr mitigates age-related bone loss by inhibiting apoptosis and enhancing osteogenesis.

Abstract

The pregnane X receptor (Pxr) regulates metabolism and inflammation, but its roles in bone homeostasis remain elusive. This study demonstrates that Pxr deficiency in bones induces osteoporotic phenotypes, with reduced trabecular bone mass, impaired osteogenesis, increased inflammation, and apoptosis. RNA sequencing reveals downregulation of the PI3K/Akt signaling pathway in Pxr-deficient bones, a key pathway linked to cell survival and differentiation. In vitro, primary bone marrow mesenchymal stem cells (BMSCs) with Pxr deficiency exhibited inhibited antioxidant enzyme activity, elevated intracellular reactive oxygen species level, activated pro-inflammatory cytokines, suppressed PI3K/Akt pathway, enhanced apoptosis, and decreased osteogenic differentiation. Conversely, Pxr overexpression in BMSCs from aged mice restores PI3K/Akt activation, mitigates apoptosis, and rescues osteogenic differentiation, with these multidirectional beneficial effects abrogated by a PI3K/Akt inhibitor. Moreover, both genetical overexpression of Pxr and pharmacological activation of Pxr improve bone quality in aged mice. These findings identify Pxr as a key regulator of bone homeostasis via the PI3K/Akt pathway, suggesting Pxr as a potential treatment target for age-related bone loss.

Figures